| Title |
Role of cannabis and endocannabinoids in the genesis of schizophrenia
|
|---|---|
| Published in |
Psychopharmacology, July 2009
|
| DOI | 10.1007/s00213-009-1612-6 |
| Pubmed ID | |
| Authors |
Emilio Fernandez-Espejo, Maria-Paz Viveros, Luis Núñez, Bart A. Ellenbroek, Fernando Rodriguez de Fonseca |
| Abstract |
Cannabis abuse and endocannabinoids are associated to schizophrenia. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 251 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 2% |
| Spain | 3 | 1% |
| Canada | 3 | 1% |
| Netherlands | 2 | <1% |
| Sweden | 1 | <1% |
| Germany | 1 | <1% |
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 233 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 47 | 19% |
| Student > Master | 35 | 14% |
| Researcher | 33 | 13% |
| Student > Ph. D. Student | 31 | 12% |
| Student > Postgraduate | 19 | 8% |
| Other | 43 | 17% |
| Unknown | 43 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 73 | 29% |
| Psychology | 43 | 17% |
| Agricultural and Biological Sciences | 35 | 14% |
| Neuroscience | 26 | 10% |
| Biochemistry, Genetics and Molecular Biology | 5 | 2% |
| Other | 15 | 6% |
| Unknown | 54 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2016.
All research outputs
#14,174,202
of 22,716,996 outputs
Outputs from Psychopharmacology
#4,052
of 5,337 outputs
Outputs of similar age
#91,971
of 110,389 outputs
Outputs of similar age from Psychopharmacology
#18
of 21 outputs
Altmetric has tracked 22,716,996 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,337 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,389 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.